|
|
|
|
||
Re: BCRX Berotralstat/Orladeyo PDUFA Even at that price, for them to reach the 500M annual rev projection would take 1250 active prescriptions per month. Within that number are the long term users like the study participants and those that want to try Orladeyo for the first time as newly diagnosed or looking for an alternative to the infusion route. In a previous presentation, Charlie Gayer mentioned surveying 10% of treating physicians covering 1300 patients. I think this was US alone. 1250 worldwide seems reachable. |
return to message board, top of board |